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STATEMENT OF JURISDICTION
The State of Kuraca and the Republic of Senhava have submitted their
differences concerning the vaccine trials to the International Court of Justice for
resolution through a Special Agreement, in accordance with Article 40(1) of the
Statute of the International Court of Justice. Both States have accepted the
jurisdiction of this Court pursuant to Article 36(2) of the Statute. The
Convention Against Torture and Other Cruel, Inhuman, or Degrading Treatment
or Punishment and the Convention on the Elimination of All Forms of
Discrimination Against Women also confer jurisdiction on this Court pursuant
to Article 36(1) of the Statute of the International Court of Justice.
STATEMENT OF THE FACTS
The State of Kuraca is a large, industrialized country with a developed
economy and an extensive higher education system. It is also a world leader in
biotechnology. The Republic of Senhava is a small, developing country
containing diverse ethnic and language groups, several of which live in total
isolation. Kuraca and Senhava have always maintained normal trading relations
with each other. However, their current relations are strained due to their
disagreement over the Multivector Hepatic Viral Disease ('"HVD") vaccine
trials.
MHVD is a deadly and contagious disease that attacks the human liver,
disrupts the digestive system, and ultimately leads to death within three years.
MHVD can be transmitted through air, water, human bodily fluid, and several
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kinds of flies and mosquitoes. MHVD was- unknown to public health
authorities until 1988, and in 1996, the World Health Organization ("WHO")
declared MHVD a worldwide pandemic. A WHO Special Panel on MHVD
found that clean water, sanitation, pest control, and avoiding unsafe sexual
practices are the only reliable defenses against the disease, but it urged that a
vaccine be developed to combat the disease.
Because a vaccine to prevent this deadly and pervasive disease is in
demand, Megaceutical Corp. ("Megaceutical"), a multinational pharmaceutical
company incorporated in Kuraca, began developing a potential MHVD vaccine.
Megaceutical conducted research to find a vaccine, and it later conducted small-
scale tests of various vaccine formulas in Senhava through its subsidiary,
Megaceutical-Senhava, Ltd. ("M-S"). Though Megaceutical is not permitted
to own more than forty-nine percent of M-S under Senhavan law, Megaceutical
retains control over M-S through a shareholder agreement.
In the Phase I (toxicity) vaccine trial conducted by M-S, two of the thirty
Senhavan test subjects developed a debilitating form of asthma. However,
Megaceutical decided to continue the vaccine trials in large populations using
a variation of the original vaccine, Vaccine 078c. M-S procured Senhava's
permission to continue the vaccine trials, at the corporation's expense, in return
for payment of an equivalent of Euros 2,000,000 to the Senhavan Health
Ministry. In return, the Senhavan Health Ministry allowed the trials to target
orphanages, prisons, maternal and child health clinics, and people in outer
island villages. Also, the Senhavan National Police were to transport M-S
personnel supervising the trials.
Megaceutical hired Dr. Maria Yukawa-Lopez to oversee the vaccine
project. Dr. Yukawa-Lopez submitted the Biomedical Research Protocol
("Protocol" or "Research Protocol") to the Kuraca Capital University
Biomedical Ethics Review Board ("Board") for its approval. Though the
Protocol included an "informed consent" form ("Consent Form"), the Board
concluded that the Senhavan test subjects were not adequately protected due to
the vulnerability of the proposed study populations, the small likelihood that
any voluntary consent would actually be fully informed, the use of placebos in
areas where the disease is active, and the absence of a credible biomedical
ethics review board in Senhava. The Board also warned that Kuracan Capital
University physicians and faculty working on these proposed vaccine trials
would risk losing their medical licenses if they proceeded to implement the
Protocol.
The Kuracan Medical Product Regulation Agency ("Agency") hired
George Smith, a citizen of Nemin, to provide on-site reporting and advisory
services to M-S. Senhava agreed to permit George Smith to perform these
services. Smith sent copies of the Research Protocol and Consent Form to the
Agency, along with his recommendation that the vaccine trials be canceled.
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After reviewing Smith's recommendation, documents, and the Board's opinion,
the Agency warned Megaceutical to halt the vaccine trials on "humanitarian"
grounds, according to an industry newsletter.
Citing these developments, Dr. Yukawa-Lopez resigned from the vaccine
project. As a result of her resignation and the Agency's warning, Megaceutical
terminated the project. Subsequently, Senhavan National Police arrested
George Smith for giving the Kuracan Medical Product Regulation Agency the
documents relating to the drug trials. Smith continues to be held without bail,
without being formally charged, and without a trial date scheduled. Kuraca has
demanded Smith be freed. On September 16, 1999, Senhava's Ministry of
Health declared a MHVD public health emergency and ordered M-S to continue
the vaccine trials or face substantial fines and imprisonment of its officers. On
September 22, after refusing to comply with Senhava's orders to continue the
vaccine trials, Senhava closed M-S's offices and continues to levy a fine of
$100,000 per day.
Kuraca maintains that it has jurisdiction to regulate its corporations and
comply with its obligations under international law regarding human rights,
while Senhava maintains that this is a Senhavan domestic health issue and thus
outside of Kuraca's prescriptivej urisdiction. Diplomatic intervention has failed
to resolve this impasse. Kuraca now petitions this Court to resolve the dispute.
Though Senhava objects to this Court's jurisdiction, both parties have agreed
to a jointly-prepared Compromise to expedite proceedings.
QUESTIONS PRESENTED
I. Whether the International Court of Justice Has Jurisdiction over this
Dispute.
II. Whether Kuraca Has Jurisdiction under International Law to Apply
Kuracan National Health Law 1006 to Megaceutical-senhava.
Im. Whether Kuraca's Laws and Regulations Protecting the Human
Rights of People Involved in Medical Experimentation Comply with its
Obligations under International Law.
IV. Whether Senhava Improperly Imprisoned George Smith for
Performing His Duties for the Kuracan Medical Product Regulation Agency.
V. Whether Senhava Should Pay Compensation for Injuries Caused by
its Breaches of International Law.
SUMMARY OF THE PLEADINGS
I. This Court has jurisdiction over this dispute based on three separate
grounds: 1) the Compromise, 2) Kuraca and Senhava's declarations accepting
this Court's jurisdiction, and 3) pre-existing treaties that confer jurisdiction on
this Court. The dispute is international in scope because human rights would
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be violated if the Research Protocol were implemented, and MVHD is a
worldwide pandemic. Thus, Senhava is divested of any claim that this is a
domestic issue. Further, Nemin is not a necessary party to this dispute, as its
rights will not form the subject-matter of this Court's judgment. In addition, the
multilateral treaty reservation is inapplicable because this case involves treaties
that codify existing customary international law.
HI. Kuraca has jurisdiction under international law to apply the Kuracan
National Health Law to M-S for five reasons. First, Kuraca has jurisdiction
under the subjective territoriality principle because Megaceutical planned the
vaccine trials. Second, Kuraca has jurisdiction under the universality principle
to protect the human rights of the Research Protocol test subjects. Third,
Kuraca has jurisdiction under the nationality principle because Megaceutical
is a national of Kuraca. Fourth, the extraterritorial application of the Kuracan
National Health Law is reasonable, in that a Kuracan corporation controls the
vaccine trials, and the human rights that would be violated in these vaccine
trials are of international concern. Fifth, the Vienna Convention on the Law of
Treaties allows Kuraca to suspend the Treaty of Amity and Commerce and thus
apply its health law to Senhava because Senhava breached the treaty first by
closing M-S's offices, threatening its officers, and fining the company.
Mll. International law prohibits the Research Protocol for three reasons.
First, human rights treaties to which both Senhava and Kuraca are parties
prohibit the Research Protocol because it endangers and exploits vulnerable
Senhavans without their free and informed consent, thereby undermining the
treaties' guarantees of human dignity and integrity. Second, the Research
Protocol specifically violates the Convention on Human Rights and
Biomedicine ("CHRB") because it does not ensure the free and informed
consent of the targeted populations and because it does not provide for a
Senhavan ethics review board. Third, the Research Protocol violates customary
international law and customary international human rights law because it
subjects the targeted Senhavans to medical experimentation without their free
and informed consent, and it does not require an ethics review board.
rV. Kuraca has authority to object to the unlawful imprisonment of
George Smith, a citizen of the Republic of Nemin, pursuant to Kuraca's interest
in Smith as its agent. Senhava violates Articles 9 and 10 of the Universal
Declaration of Human Rights by arbitrarily arresting Smith and holding him
without bail, without presenting formal charges, and without setting a trial date.
V. Customary international law dictates that Senhava should pay
compensation for all damages resulting from its breaches of the Treaty of Amity
and Commerce, the Convention on the Elimination of All Forms of
Discrimination Against Women, the Convention Against Torture and Other
Cruel, Inhuman, or Degrading Treatment or Punishment, and the Convention
on the Rights of the Child. Further, Senhava should return the payment of
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Euros 2,000,000 previously advanced by Megaceutical, pay for all damages
resulting from the closing of M-S, and cease all conduct from which the
breaches arise.
PLEADINGS AND AUTHORITIES
I. THE INTERNATIONAL COURT OF JUSTICE HAS
JURISDICTION OVER TIs DISPUTE
This Court has jurisdiction based on the declarations of Kuraca and
Senhava accepting this Court's compulsoryj urisdiction,' the Compromise,2 and
treaties which directly confer jurisdiction on this Court Senhava asserts that
this Court lacks jurisdiction because: 1) The dispute exclusively concerns
matters which are essentially within the domestic jurisdiction of Senhava, as
determined by Senhava; and 2) the Republic of Nemin is not a party to the case.
However, norms of international law do not support Senhava's objections to
this Court's jurisdiction, regardless of which basis for jurisdiction the
objections are applied.
A. Senhava's Domestic Jurisdiction Objection does not Divest this Court
of Jurisdiction
In an apparent attempt to reciprocally assert Kuraca's domestic jurisdiction
reservation, Senhava urges that the issues in this case "are purely internal to
Senhava"4 and attempts to take advantage of the subjective clause of Kuraca's
reservation.5 However, whether Senhava asserts its domestic jurisdiction
objection through the doctrine of reciprocity or through its own "reservations"
to the Compromise, the objection is not supported by international law.
1. See Statute of the International Court of Justice, June 26, 1945, art. 36, para. 2, 59 Stat. 1055,
T.S. 993 [hereinafter I.CJ. Statute].
2. See I.CJ. Statute, supra note 1, art. 36, para. 1. See also J. G. Merrills, The Optional Clause
Revisited, 64 BRrr. Y.B. INTL L 197, 198 (1993); SHABTMi ROSENNF, THE LAw AND PACICE OF THE
INmTE-ATIONAL CouRT 333,370 (2d ed. 1985); RENATASZAFARZ, THE COMPULSORY JURISDICION OFTHE
IMRNATIONAL COURT OF Jusnca 6-7 (1993).
3. See LCJ. Statute, supra note 1, art. 36, para. 1. See, e.g., Convention Against Torture and
Other Cruel, Inhuman, or Degrading Treatment or Punishment, opened for signature Dec. 10, 1984, art 30,
para. 1, 1465 U.N.T.S. 85, 121 [hereinafter CAT]; Convention on the Elimination of All Forms of
Discrimination Against Women, opened for signature Dec. 18, 1979, art. 29, 1249 U.N.T.S. 13, 34
[hereinafter CEDAW]; see also discussion infra Part 111.B.1.
4. Comp. Issues/Claims p. 13.
5. See Comp. & 34.
Distinguished Brief
1. The Dispute is International in Scope
The scope of the disagreement between Kuraca and Senhava is essentially
international for two reasons: 1) The facts underlying this dispute are
international in character; and 2) even if the dispute is domestic, Senhava's
participation in multilateral treaties has elevated the dispute to an international
realm. First, the facts have international implications. Because the WHO
declared MHVD a worldwide pandemic,6 concerns about the disease transcend
the borders of Senhava. The ease of MHVD's transmission7 demonstrates that
the pandemic is not localized to Senhava and that it requires an international
response. Moreover, this dispute ultimately turns on the international law of
human rights. As questions of human rights in the medical experimentation
context hold a significant position in international law,8 this case is properly
characterized as essentially international in nature.
Second, to the extent that Megaceutical's vaccine trials may be domestic
in nature, Senhava has elevated that domestic subject matter to an international
level by its assent to treaties implicated by the trials. The "theory of relativity"
accords international status to issues otherwise domestic when a country enters
into an international agreement concerning those same issues.9 Because this
Court must interpret treaties to which Senhava is a party or has signed,"0 the
dispute is plainly international.
2. Senhava should not be Permitted to Subjectively Determine whether this
Dispute is Essentially Domestic in Nature
Senhava should not be permitted to determine this Court's jurisdiction
because: 1) the subjective clause is invalid; and 2) Senhava waived its ability
to rely on the subjective clause.
a. The Subjective Clause is Invalid
Senhava should not be able to assert the subjective clause, reciprocally or
through its own reservation contained in the Compromise, because it is invalid.
According to the Vienna Convention on the Law of Treaties ("Vienna
6. See id. & 6.
7. See id. & 5.
8. See generally Frncesco Francioni, An International Bill of Rights: Why it Matters, How it Can
Be Used, 32 TEX. IN'L LJ. 471,481 (1997); see also discussion infra Part IM.A.
9. See Certain Norwegian Loans (Pr. v. Nor.), 1957 LC.J. 9, 23-25; Interhandel (Switz. v. U.S.),
1950 I.CJ. 6, 24 (Mar. 21); Interpretation of Peace Treaties with Bulgaria, Hungary, and Romania, 1950
LCJ. 65, 70-71 (Mar. 30); Advisory Opinion No. 4, Nationality Decrees Issued in Tunis and Morocco
(French Zone) on November 8, 1921, 1923 P.C.LJ. (ser. B) No. 4, at 24.
10. See infra Part 11.B..
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Convention"), the subjective clause is prohibited by the Statute of the
International Court of Justice ("Statute") and therefore is void. The Statute
requires that "in the event of a dispute as to whether the Court has jurisdiction,
the matter shall be settled by a decision of the Court."" The United Nations
Charter and the Statute support the above mandate by declaring that this Court
"shall function in accordance with the . . . Statute."' 2 Accordingly, the
reservation is void under the Vienna Convention, which clearly states that a
state may formulate a reservation "unless the reservation is prohibited by the
treaty."' 3  Furthermore, since the Vienna Convention codified customary
international law regarding reservations, 4 the clause is also invalid under
customary international law.
The invalidity of the subjective clause of Kuraca's reservation does not
invalidate Kuraca's entire declaration. The Vienna Convention permits an
invalid clause to be separated from a treaty where: 1) The separation does not
interfere with the application of the remainder of the treaty; 2) the voided clause
was not an essential basis for the acceptance of the other parties to the treaty;
and 3) the continued performance of the treaty would not be unjust. 5 The
elements are easily satisfied: 1) The declaration will function as if the invalid
clause never existed; 2) as other states chose not to make the same reservation
to their declarations, it may be inferred that no state would have based its
acceptance on Kuraca's subjective clause; and 3) the continued utilization of
the optional clause is not unjust, as the result is equally binding on all parties
that have submitted declarations. However, even if Kuraca's declaration were
deemed invalid, the Compromise 6 and the treaties 7 provide a second and a
third basis for jurisdiction.
b. Senhava Waived the Ability to Assert the Subjective Clause
The Compromise acknowledges this Court's ability to determine its own
jurisdiction in three instances. 8 In agreeing to submit this dispute to this Court,
Kuraca detrimentally relied on the Senhavan assertions that this Court had the
ability to determine its own jurisdiction to the extent that Kuraca by-passed
It. I.C.J. Statute, supra note 1, art. 36, para. 6 (emphasis added).
12. U.N. CHARTER art. 92; I.C.J. Statute, supra note 1, art. 1.
13. Vienna Convention on the Law of Treaties, opened for signature May 23, 1969, art. 19, 1155
U.N.T.S. 331, 336-37 [hereinafter Vienna Convention]. See also Certain Norwegian Loans 1957 I.C.J. at
43-49 (separate opinion of Judge Lauterpacht); SZARARZ, supra note 2, at 54.
14. See James Crawford, The Legal Effect of Automatic Reservations to the Jurisdiction of the
International Court, 50 BRrr. Y.B. INTLL 63,79 (1981).
15. Vienna Convention, supra note 13, art. 44, para. 3,1155 U.N.T.S. at 343.
16. See supra note 2.
17. See supra note 3.
18. See Comp. preamble & art. 1.
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alternative methods of dispute resolution, such as the arbitration provisions
mandated by treaties implicated in this dispute. 9 Accordingly, Senhava should
be estopped from denying this Court the ability to determine its own jurisdic-
tion.2°
3. If Senhava is Permitted to Determine the Character of this Dispute, then
the Duty of Good Faith Prevents Senhava from Characterizing this Dispute
as Essentially Domestic
The Vienna Convention2 and general principles of international law22
require treaties to be performed in good faith. Indeed, this Court explained that
"[i]n the establishment of this [network of reservations] which constitutes the
Optional-Clause system, the principle of good faith plays an important role. 23
The decidedly international character of this dispute and the theory of
relativity' preclude a good faith characterization of this dispute as essentially
domestic.
B. Nemin's Absence does not Divest this Court of Jurisdiction
Senhava's argument that this Court lacks jurisdiction due to Nemin's
absence implicates two issues of international law: 1) the application of the
necessary party doctrine and 2) the application of the multilateral treaty
reservation, either reciprocally through Kuraca's declaration or through the
Compromise. Neither implication divests this Court of jurisdiction.
1. The Necessary Party Doctrine is not Applicable in this Case
The necessary party doctrine applies in cases where an absent state's rights
would "constitute the very subject matter of' this Court's judgment.' In other
words, the doctrine applies when the absent state's rights form the "basis" for
the judgment, and not simply where the Court's judgment "might well have
implications" for the absent state's rights.26
19. See CAT, supra note 3, art. 3, para. 1, 1465 U.N.T.S. at 121; CEDAW, supra note 3, art. 29,
para. 1, 1249 U.N.T.S. at 34.
20. See Tle Territorial Dispute (Libya/Chad), 1994 I.C.J. 6 (Feb. 3) (separate opinion of Judge
Ajibola).
21. Vienna Convention. supra note 13, art. 26, 1155 U.N.T.S. at 339.
22. See J.F. O'CONNER, GOOD FAITH IN INTERNATIONAL LAW 98 (1991).
23. Military and Paramilitary Activities in and Against Nicaragua (Nicar. v. U.S.), 1984 I.C.J. 392,
418 (Nov. 26).
24. See discussion supra Part I.A.1.
25. East Timor (Port. v. Austl.), 1995 I.C.J. 90, 105 (June 30).
26. East Timor, 1995 I.C.J. at 105.
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Nemin has two peripheral connections to this dispute: 1) its national,
George Smith, has been unlawfully imprisoned by Senhava;2 7 and 2) Nemin is
a party to several multilateral treaties to be interpreted by this Court.' These
insubstantial connections cannot form the basis for this Court's judgment.
First, Nemin's rights vis-k-vis George Smith will remain unchanged since his
nationality is not at issue here. While a judgment of this Court will indeed
affect the rights of George Smith, the rights of Nemin are not implicated.
Second, although Nemin is a party to several multilateral treaties that this Court
must construe, Nemin's rights will not be affected because a decision of the
Court "has no binding force except between the parties" to the case.2 Thus,
Nemin's meager connections do not form the basis of the dispute.
2. The Multilateral Treaty Reservation is not Applicable in this Case
The multilateral treaty reservation protects states such as Kuraca from
having the terms of a treaty construed with regard to itself, while other parties
to the same treaty are able to assert the non-binding nature of any judgment of
this Court as a defense for non-compliance with the Court's construction of a
treaty.3 This Court has explained that there is no danger of prejudice to parties
of a case or to absent parties when the Court merely construes customary
international law codified in multilateral treaties.3 Thus, this reservation is
inapplicable as the treaties at issue are codifications of customary international
law. 32
II. KURACA HAS JURISDICTION UNDER INTERNATIONAL LAW TO APPLY
KURACAN NATIONAL HEALTH LAW 1006 TO MEGACEUTICAL-SENHAVA
Despite the fact that Senhava bears the burden for proving that the
extraterritorial application of the Kuracan National Health Law ("Health Law")
is illegal,33 Kuraca advances three independent bases of jurisdiction for its
extraterritorial application of the law: 1) the subjective territoriality principle,
2) the universality principle, and 3) the nationality principle. Kuraca's
application of its law under these bases is reasonable. Furthermore, the Treaty
27. See Comp. & 25; Clar. & 9.
28. See Clar. & 8.
29. I.C.J. Statute, supra note 1, art. 59.
30. See STANIMI A. ALEXANDROPOV, RSERVATIONSINUNILATERALDECLARATIONS ACCEPTING
THE COMPULsORY JURISDICION O THE INIERNATIONAL COURT OF JUSTICE 112-19 (1995).
31. See Military and Paramilitary Activities in and Against Nicaragua (Nicar. v. U.S.), 1986 LC.J.
14, 94-96 (June 27).
32. See infra Parts M.A., II1B.3.
33. See S.S. Lotus, 1927 P.C.LJ. (set. A) No. 10, at 18.
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on Amity and Commerce ("TAC") does not affect Kuraca's ability to assert
jurisdiction over M-S.
A. Kuraca has Jurisdiction under the Subjective Territoriality Principle
According to the subjective territoriality principle, Kuraca has jurisdiction
over infractions "commenced within the state, but completed or consummated
abroad."' The vaccine trials regulated by the Health Law fit squarely within
this definition. While the trials were conducted in Senhava through M-S,
planning and substantial research was no doubt done at the company's
headquarters in Kuraca, where its principal laboratories and drug processing
facilities are located.35 Indeed, Megaceutical initiated the idea for the MHVD
vaccine project and hired Dr. Maria Yukawa-Lopez to head the project.36 Most
importantly, Megaceutical controls all of its Senhavan satellite's "small scale"37
operations through a shareholder agreement." Megaceutical's orchestration of
the vaccine trials is also analogous to previous applications of the subjective
territoriality principle where states asserted jurisdiction based on the planning
of, or even a single act of, a fraudulent transaction occurring within its
territory."
B. Kuraca has Jurisdiction under the Universality Principle
The universality principle allows jurisdiction over foreign nationals
"where the circumstances.. . justify the repression of some types of crime as
a matter of international public policy."' International human rights law has
gained such stature that some scholars comment that "the principle of
sovereignty is not necessarily a bar to intervention within another nation's
domestic affairs regarding the protection of international human rights." '
Thus, this Court should permit Kuraca to apply its law extraterritorially under
34. IAN BROWNLEE, PRINCIPLES OF PUBLIC INTERNATIONAL LAW 303-04 (511H ED. 1998);
INTERNATIONAL LAW ASSOCIATION, REPORT OF THE FInqY-Fn'rn CONFERENCE 139 (1972); RESTATEMENT
(THIRD) OFTIIE FOREIGN RELATIONS LAW OF TIE UNITED STATES § 402 (1987) [hereinafta RESTATEMENT].
35. See Comp. & 9.
36. See id. & 12.
37. Id. &9.
38. See id. & 10.
39. See Libman v. T[e Queen, [1985] 2 S.C.R. 178, 212-13 (Can.); see also Lzasco Data
Processing Equip. Corp. v. Maxwell, 468 F.2d 1326, 1334 (2nd Cir. 1972).
40. See BROWNLE, supra note 34, at 307.
41. William C. Plouffe, Sovereignty in the "New World Order": The Once and Future Position
of the United States, A Merlineseque Task of Quasi-legal Definition, 4TJLSAJ. COMP. & INTLL 49,59-60
(footnote omitted) (1996); see also discussion supra Part LA.1 and discussion infra Part l.A.
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the universality principle in order to prevent further human rights abuses in
Senhava.42
C. Kuraca has Jurisdiction under the Nationality Principle
The nationality principle "is also generally recognized as a basis for
jurisdiction over extra-territorial acts."' 3 Thus, Kuraca should be able to apply
its Health Law to M-S because it is a national of Kuraca.
1. General Principles of International Law Hold that a Subsidiary Corpora-
tion should be Treated as a National of the Country from which its Parent
Corporation Controls it
The nationality of a parent corporation determines the nationality of a
subsidiary corporation in many contexts, especially when the parent controls
the affairs of the subsidiary. Numerous international agreements cite the
controlling parent corporation's nationality as the determining factor," and
various courts have held it determinative of the subsidiary's nationality.45
Furthermore, in an analogous situation, countless courts have based liability of
a parent corporation on its control of a subsidiary.' Thus, given Senhava's
concession that Megaceutical effectively controls M-S,47 the subsidiary is a
national of Kuraca.
42. See infra Part 111.B.3.
43. See BROWNLE, supra note 34, at 306.
44. See, e.g., 1982 U.N. Convention on the Law of the Sea, opened for signature Dec. 10, 1982,
art. 153, para. 2, 1833 U.N.T.S. 33, 455; Declaration of the Government of the Democratic and Popular
Republic of Algeria Concerning the Settlement Claims by the Government of the United States of America
and the Government of the Islamic Republic of Iran, Jan. 19, 1981, art. vii, para. 1, 1 Iran-U.S. Cl. Trib. Rep.
9, 11 (1983), 20 I.LM. 223, 232-33 (1981); Convention on the Settlement of Investment Disputes between
States and Nationals of other States, opened for signature Mar. 18, 1965, art. 25, 575 U.N.T.S. 159, 174;
Draft Convention Concerning Recognition of the Legal Personality of Foreign Companies (Societies),
Associations, and Foundations, opened for signature Oct. 31, 1951, art. II, 40 Revue Critique de Droit
International (Fr.) 724, reprinted in I AM. 1. ComP. L. 277, 277-78 (1952). Cf. Convention Relating to the
Mutual Recognition of Companies and Legal Persons, Feb. 29,1968, art. 3-5, 2 Common Mkt. Rep. (CCH)
5211 (1968).
45. See, e.g., Societe Magnet & Garuz v. X, Cour d'appel de Montpellier, May 3, 1926 [1926], S.
Jur.I1. 75 (Fr.); Daimler Co. v. Continential Tyre & Rubber Co. (Great Britain) Ltd., [1916] 2 App. Cass. 307,
340-41 (H.L.) (Eng.); Societe W. Canadian Collieries v. Vanverts, Tribunal civil de Lille, May 21, 1908,
[1910], D. P. 11. 41 (Fr.).
46. See, e.g., Denty v. SmithKline Corp., 907 F. Supp. 879 (E.D. Pa. 1995); Case 202/85,
Commission Decision of 19 December 1984 relating to a Proceeding Under Article 85 of the EEC Treaty
(Wood Pulp), 1985 O.J. (L 85) 1; Mas Marques v. Digital Equip. Corp., 490 F. Supp. 56,58 (D. Mass. 1980);
Joined Cases 6 & 7/73, Instituto Chemioterapico Italiano SpA & Commercial Solvents Corp. v. Commission,
1974 E.C.R. 223; Case 48/69, Imperial Chem. Indus., Ltd. v. E.E.C. Commission 1972 E.C.R. 619, 662.
47. See Comp. IN 10, 31.
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While section 213 of the Restatement (Third) of the Foreign Relations Law
of the United States ("Restatement") seems to indicate that a corporation's
nationality should be determined by its state of incorporation," this rule is not
absolute. For example, the comments to section 213 explain that "[a] state
cannot, by requiring a foreign enterprise to incorporate locally, compel the
enterprise to surrender... protection by the state of its parent corporation."'49
Accordingly, as M-S is required under Sehavan law to incorporate in Senhava, °
the Restatement is inapplicable.
2. Barcelona Traction is Inapplicable under the Facts of this Case
In Barcelona Traction, this Court held that a corporation's nationality
should be determined by "the laws of which it is incorporated and in whose
territory it has its registered office.""1 However, the corporation in Barcelona
Traction had free choice in selecting its country of incorporation,52 whereas, M-
S was forced to incorporate in Senhava.53 But most importantly, the corpora-
tion in Barcelona Traction had a "close and permanent connection" with its
state of incorporation,5 4 as opposed to the tenuous ties between M-S and
Senhava.
D. Kuraca's Application of Kuracan National Health Law 1006 is Reason-
able
The Restatement requires any assertion of jurisdiction be "reasonable" in
addition to satisfying one of the traditional grounds for jurisdiction.5 The
reasonableness of Kuraca's extraterritorial assertion of its Health Law is
evident in that: 1) The drug testing has a strong link to Kuraca resulting from
Megaceutical's control of the tests;56 2) the nationality of the individual being
regulated is Kuracan;57 and 3) human rights are a serious national concern
within Kuraca, as well as on an international scale. 8 This is true despite the
48. See RESTATEMENT, supra note 34, § 213.
49. Id. cmt. 3.
50. See Comp. 1 10.
51. Barcelona Traction, Ught, and Power Co. (Belg. v. Spain), 1970 I.C.J. 3, 42 (Feb. 5).
52. See Barcelona Traction, 1970 I.C.J. at 42.
53. See Comp. 10.
54. Barcelona Traction, 1970 I.C.J. at 42.
55. See RESTATEMENT, supra note 34, § 403.
56. SeeComp. t llO, 31.
57. See supra Part B.C.
58. See Kuracan National Health Law, 1006 § 6(aXl); see also discussion supra Parts I.A.1., I.B.
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fact that the reasonableness standard is not binding on Kuraca, as it does not
properly reflect international law.59
E The Treaty of Amity and Commerce does not Prevent Kuraca from
Applying the National Health Law Extraterritorially
Though the TAC states that Kuraca and Senhava submit "themselves to all
laws and regulations applicable to them,' " this does not preclude Kuraca's
extraterritorial application of its law due to Senhava's prior material breach of
the treaty. When the Health Law first affected M-S, the law conflicted with no
Senhavan laws. Only in reaction to the Health Law did the Senhavan
government begin treating M-S as if it was acting illegally. Indeed, Senhava
attempted to force M-S to conduct drug trials via a government order,
threatened its officers with substantial fines and imprisonment, and eventually
shut the company down."' This treatment constitutes material breach of the
treaty in that Senhava did not permit M-S, a Kuracan national, to carry on trade
"upon the same terms as Senhava's nationals are permitted to" in Kuraca.62 It
is reasonable to infer that Senhavan companies operating in Kuraca have been
treated well based on the countries' thirty-two year history of normal trading
relations.63 Thus, the Vienna Convention permits Kuraca to suspend the
treaty's operation and apply its Health Law extraterritorially."
I. KURACA MUST APPLY NATIONAL HEALTH LAW 1006 REGARDING
BIOMEDICAL RESEARCH ON HUMANS TO MEGACEUTICAL AND ITS SUBSID-
IARY BECAUSE IT EMBODIES INTERNATIONAL LAW
A. Human Rights are a Matter of International Concern and are Governed
by International Law
International law protects human rights. Since at least the end of the
Second World War, the international system has transformed from one which
values state sovereignty above all else to one which recognizes that there are
inviolable human rights involving the dignity and integrity of people that no
state may violate.6' The United Nations Charter, a clear indicator of the
59. See David B. Massey, How the American Law Institute Influences Customary Law: The
Reasonableness Requirement of the Restatement of Foreign Relations law, 22 YALE J. INT'L L. 419, 444
(1997).
60. Clar. 10.
61. See Comp. 130.
62. See Car. '110.
63. See id. 12.
64. See Vienna Convention, supra note 13, art. 60, 1155 U.N.T.S. at 346.
65. See Louis Henkin, Human Rights and State "Sovereignty, " 25 GA. J. INT'L & COMP. L 31, 33-
34 (1995/1996).
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international protection afforded to human rights, reaffirms in its preamble
"faith in fundamental human rights [and] in the dignity and worth of the human
person."' Both Senhava and Kuraca are members of the United Nations
("U.N.") and are bound by the provisions of the Charter. Further, the U.N.'s
Universal Declaration of Human Rights, which guarantees equality in dignity
and rights,6" embodies customary international law." The Convention on the
Elimination of All Forms of Discrimination Against Women ("CEDAW"),69 the
Convention Against Torture and Other Cruel, Inhuman, or Degrading Treatment
or Punishment ("CAT"),7" and the Convention on the Rights of the Child
("CRC"),7 key human rights treaties that guarantee human dignity and to which
Senhava and Kuraca are parties, also embody customary international law.72
B. International Law Prohibits Conducting the MHVD Biomedical
Research Protocol in Senhava
Because the Research Protocol violates multilateral human rights treaties,
customary international law, and customary international human rights law, this
Court should uphold Kuraca's rejection of the MVHD vaccine trials in
Senhava.
1. Treaties to which Senhava and Kuraca are Parties
Prohibit the Research Protocol
The CEDAW, the CAT and the CRC all guarantee human dignity and
integrity.73 Advances in biomedics and life sciences may undermine these
guarantees, thereby invoking the application of these human rights treaties
when conducting human experimentation.74 The World Conference on Human
Rights officially links medical ethics with human rights based on the ways in
66. U.N. CHARTER preamble.
67. U.N. G.A. Res. 217, U.N. GAOR, 3d Sess., U.N. Doc. A/810 (1948).
68. See, e.g., Montreal Statement of the Assembly for Human Rights (1968), reprinted in 9 J. INT'L
CoMM. JuRISTS REv. 94 (1968); Declaration of Tehran, Final Act of the International Conference on Human
Rights, U.N. Doc. A/CONF.32/41 (1968), reprinted in UNrrED NATIONS, HuMAN RIGHTS, A COMPILAnON
OF INTERNATIONAL INsrRuMENTs 43 (1988).
69. See CEDAW, supra note 3, 1249 U.N.T.S. 13.
70. See CAT, supra note 3, 1465 U.N.T.S. 113.
71. See Convention on the Rights of the Child, openedfor signature Nov. 20,1989,1577 U.N.T.S.
3 [hereinafter CRC].
72. See supra notes 67, 68.
73. See CEDAW, supra note 3, preamble, 1249 U.N.T.S. at 14; CAT, supra note 3, preamble, 1465
U.N.T.S. at 113; CRC, supra note 7 1, preamble, 1577 U.N.T.S. at 44.
74. See Sonia Le Bris et al., International Bioethics, Human Genetics, and Normativity, 33 HOUS.
L REV. 1363, 1364-65 (1997); Vienna Declaration and Program of Action, U.N. GAOR, 48th Sess., pt. I,
22d mtg.P1, U.N. Doc. A/CONF.157.24 (1993), 32 L.LM. 1661, 1667 (1993).
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which ethics and health sciences concern fundamental questions throughout the
world with regard to all humans."' The Research Protocol violates the
guarantee of human dignity and integrity because it does not provide for free
and informed consent, as it targets the most vulnerable populations of
Senhava 6
The Research Protocol also violates specific human rights protections
ensured in the CEDAW, the CAT and the CRC. The CEDAW provides for the
elimination of "all forms of discrimination and... promot[ing] equal rights for
men and women."" Because the Protocol targets women in maternal clinics,
it violates the CEDAW by discriminatorily targeting women in health clinics
to the dangerous Vaccine 078c. The CAT prohibits states from, among other
things, treating people in cruel, inhuman or degrading ways.78 Subjecting
disadvantaged populations to the random risk of suffering from debilitating
asthma is degrading and inhuman- sacrificing their bodily integrity and human
worth without first securing their free and informed consent. The introductory
note to the CRC states that the CRC is intended to encompass the "protection
of children ... against medical experimentation., 79 This language was not
specifically included in the treaty- though clearly within the scopeof it- because
of the "last minute rush" in preparing the final version of the CRC. 0 The
Protocol violates the intent of the CRC because it specifically targets children
in health clinics and orphans."
2. The Convention on Human Rights and Biomedicine Prohibits the
Research Protocol
The Convention on Human Rights and Biomedicine ("CHRB") reiterates
that human rights protect human dignity. 2 Article 5 declares that "intervention
in the health field may only be carried out after the person concerned has given
free and informed consent to it." 3 Article 16 requires the satisfaction of five
conditions before research may be conducted on humans. One of these
75. See Le Bris et al., supra note 74, at 1364-65; Jean-Louis Baudouin, Reflexions sur les Rapports
de la Bioethique et des Droits Fondamentaux, in EmIQUE ET DROrrs FONDAMENTAUX 147, 149 (Guy
LaFrance ed., 1989).
76. See infra Part M.B.3.c.
77. CEDAW, supra note 3, preamble, 1249 U.N.T.S. at 13.
78. CAT, supra note 3, art. 16, 1465 U.N.T.S at 116.
79. Convention on the Rights of the Child, Introductory Note, U.N. Doc. E/CN.4/1989/48 (1989),
28 I.LM. 1448,1451 n.22.
80. See id.
81. See Comp. I 15.
82. See Convention on Human Rights and Biomedicine, opened for signature Apr. 4, 1997,
preamble, 36 LLM. 817. 821 [hereinafter CHRB].
83. Id. art. 5, at 821 (emphasis added).
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conditions restates Article 5, thereby emphasizing its importance. Another
condition is approval of the research project by a "competent body after
independent examination. '84 The Research Protocol violates the voluntary,
informed consent provisions of Articles 5 and 16, and it violates Article 16's
requirement of a competent ethics review board. As discussed in Part Il.B.3.c.,
the targeted research populations are also Senhava's most vulnerable, thereby
undermining the possibility of any voluntary, informed consent. Further,
Senhava has no ethics review board, much less a competent one, and Kuraca's
ethics review board has banned the Research Protocol.
85
Senhava and Kuraca have signed the CHRB, and their ratifications are
pending. 6 Therefore, Article 18 of the Vienna Convention, to which Senhava
and Kuraca are parties, obligates them to "refrain from acts which would defeat
the object and purpose of a treaty" because they have "signed the treaty. 81
Conducting research trials which directly violate specific provisions of the
CHRB and which undermine its preamble's stated purpose of respecting human
dignity would defeat the object and purpose of the CHRB.
3. The Research Protocol Violates Customary International Law and
Customary International Human Rights Law because it does not Ensure
Adequate Informed Consent and because it does not Provide for an Ethics
Review Board
a. There is a Lower Threshold for Establishing Customary International
Human Rights Law, as Opposed to Customary International Law
Generally, to prove the existence of a norm as customary international law,
the norm must be 1) an identifiable state practice and 2) recognized as
obligatory and legally binding.88 In North Sea Continental Shelf, this Court
found that multilateral conventions may generate rules which crystallize
customary international law after meeting certain conditions: 1) the rule must
be of a "norm-creating character such as could be regarded as forming the basis
of a general rule of law;" 2) there must be widespread participation in the
Convention, particularly those states whose interests are specifically affected;
and 3) there must be opinio juris reflected in near uniform State practice,
though "the passage of only a short period of time is not necessarily, or of itself,
a bar to the formation of a new rule of customary international law.
819
84. Id. art. 16, at 822.
85. See Comp. 123.
86. See id. 13.
87. Vienna Convention, supra note 13, art. 18, 1155 U.N.T.S. at 336; see also Comp. 13.
88. See North Sea Continental Shelf (FRG/Den.; FRG/Neth.), 1969 I.C.J. 3,43-44 (Feb. 20).
89. North Sea Continental Shelf, 1969 LC.J. at 41-42. See also SIR IAN SINCLAIR, THE ViENNA
CONVEN11ON ON THE LAW OF TREATiES 22 (1984).
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In the realm of human rights, however, the standard for establishing
customary international law is different. In Military and Paramilitary Activities
in and against Nicaragua, this Court emphasized opinio juris as the crux of
establishing law with regard to protecting humans.' Section 701 of the
Restatement states that "the practice of states that is accepted as building
customary international law of human rights includes some forms of conduct
different from those that build customary international law generally";9 "it is
not based on consent ... it does not honor or accept dissent, and it binds
particular states regardless of their objection."'
b. Customary International Law and Customary International Human
Rights Law Require Voluntary, Informed Consent and a Competent Ethics
Review Board when Conducting Biomedical Research
i. The Convention on Human Rights and Biomedicine Embodies Customary
International Law and Customary International Human Rights Law Requir-
ing Informed Consent and an Ethics Review Board
Even if Senhava and Kuraca were not bound to further the object and
purpose of the C-RB,9 it has become part of customary international law
because the provisions of informed consent and an ethics review board do not
include any secondary obligations; in other words, they are internationally
practiced without any additional conditions, thereby fulfilling North Sea
Continental Shelf s first requirement.' Second, there is widespread participa-
tion in the CHRB; twenty-four of the members of the Council of Europe have
signed it, as well as Senhava and Kuraca. Finally, as discussed below, the
CHRB reflects opiniojuris, which independently elevates informed consent and
the requirement of an ethics review board to the status of customary interna-
tional human rights law.
The Explanatory Report to the CHRB states that one of the CHRB's
purposes is to "harmonize existing standards;" 5 it builds on human rights law
that already exists. The CHRB further states that it is consistent with
International Covenant on Economic, Social and Cultural Rights' and the CRC,
90. See Military and Paramilitary Activities in and against Nicaragua (Nicaragua v. U.S.), 1986
I.C.J. 14, 98-108 (June 27).
91. RESTATEMENT, supra note 34, § 701 n.2.
92. Henkin, supra note 65, at 38.
93. See discussion supra Part m.B.2.
94. See North Sea Continental Shelf, 19691.C.J. at 41.
95. Explanatory Report to the Convention on Human Rights and Biomedicine, authorized Dec. 17
1996, 36 LLM. 826, 827 (emphasis added).
96. Open for signature Dec. 16, 1966, 993 U.N.T.S. 3, 5.
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treaties which are currently in force and to which Senhava is a party. 97 By
signing the CHRB, Senhava and Kuraca indicated their intent to be bound and
their belief that they should be bound by the CHRB's provisions." As such, the
CHRB constitutes opinio juris.
ii. The Declaration of Helsinki and the Nuremberg Code are Customary
International Human Rights Law Requiring Informed Consent and an Ethics
Review Board
The Nuremberg Code" and the World Medical Association Declaration
of Helsinki" ("Declaration of Helsinki") reflect opiniojuris. The Nuremberg
Code consists of ten principles, articulated in the final judgment of the trial of
Nazi doctors who were indicted for and convicted of crimes against humanity
committed during World War II."' The first principle is: "The voluntary
consent of the human subject is absolutely essential."1°2 The Nuremberg Code
has been described as "[tihe most complete and authoritative statement of the
law of informed consent" and "part of international common law... [which]
may be applied in both civil and criminal cases.""0 3
The Declaration of Helsinki builds on the Nuremberg Code." 4 In addition,
it implements the requirement of an ethics review board."' Both are "widely
known international codes of ethics for the protection of human subjects."' 6
International texts and legislation recognize the Declaration of Helsinki as
international law regarding human experimentation, and medical organizations
97. See CHRB, supra note 82, preamble, 36 I.LM. at 821.
98. See NICARAGUA, 1986 I.CJ. at 98-108; RESTATEMENT, supra note 34, § 701 n.2; Hurst
Hannum, The Status of the Universal Declaration of Human Rights in National and International Law, 25
GA. J. INT'L & COMP. L. 287, 318-20 (199511996); Henkin, supra note 65, at 36-38; THEODOR MERON,
HUMAN RIGHTS AND HUMANrAIAN NORMS AS CUSTOMARY LAW 108-13 (1989).
99. Tribunals of War Criminals before the Nuremberg Military Tribunals Under Control Council
Law No. 10, Vols. I and III (Washington D.C.: U.S. Government Printing Office, 1949), Vol. II, 181
[hereinafter Nuremberg Code].
100. WORLD MEDICALAS TION DE TION OP HELSINKI V, 48th World Medical Assembly,
Somerset, South Africa, 1996 [hereinafter Declaration of Helsinki].
101. See Michael A. Grodin, Historical Origins of the Nuremberg Code, in THENAZI DOCTORS AND
THE NUREMBERG CODE: HUMAN RIGHTS IN HUMAN EXPERIMENTATION 121, (George J. Annas & Michael
A. Grodin eds., 1992) [hereinafter NAZI DOCTORS].
102. Nuremberg Code, supra note 99.
103. GEORGE J. ANNAS ETAL., INFORMED CONSENT TO HUMAN EXPERIMENTATION 1 (1977); SEE
ALSO 4 ENCYa.OPEDIA OF BIOETHICS 1746-82 (Warren Reich ed., 1978).
104. See Declaration of Helsinki, supra note 100, art. 1.9.
105. See id. art. L2.
106. leana Dominquez-Urban, Harmonization in the Regulation of Pharmaceutical Research and
Human Rights: The Need to Think Globally, 30 CORNELL INT'L L J. 245, 273 (1997).
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accept it internationally."° It has also been cited as constituting the basis of
"universality in the field of ethical-moral standards in human experimenta-
tion. ' 8
The Nuremberg Code and the Declaration of Helsinki are modem
clarifications of medical ethics followed worldwide, necessary because of
advances in medicine heralded with new technology and the internationalization
of disease caused by increased international travel."° Indeed, the Nuremberg
Code has its ethical roots in Percival's code of medical ethics, requiring
researchers to be conscientious and responsible, and in Beaumont's code of
medical ethics, requiring the same, as well as a statement of voluntary,
informed consent. It builds on the Hippocratic oath, which obligates doctors
to, do no harm to their patients." °  More modem manifestations of the
Nuremberg Code and the Declaration of Helsinki include the International
Covenant on Civil and Political Rights, which requires voluntary consent,"' the
Principles for Those in Research and Experimentation, which requires informed
consent,1 2 the International Ethical Guidelines for Biomedical Research
Involving Human Subjects, issued by the Council for International Organiza-
tions of Medical Sciences in collaboration with the WHO ("WHO/CIOMS
Guidelines") and requiring informed consent as well as approval of an ethics
review board,"3 and many other international instruments.1
4
107. See Sharon Perley et al., The Nuremberg Code: An International Overview, in NAZDOCrORS,
supra note 101, at 159 (citing M. Cheriff Bassiouni et al., An Appraisal of Human Experimentation in
International Law and Practice: The Need for International Regulation of Human Experimentation, 72 J.
CRIM. L & CRIMINOLOGY 1587,1611 (1981)).
108. Id. at 160 (citing William Curran, Subject Consent Requirements in Clinical Research: An
International Perspective for Industrial and Developing Countries, in HUMAN EXPERIMENTATION AND
MEDICAL ETHICS (Zbigniew Bankowski & Norman Howard-Jones eds., 1982)).
109. See David P. Fidler, The Globalization of Public Health: Emerging Infectious Diseases and
International Relations, 5 IND. J. GLOBAL LE.GAL STUD. 11, 14-15 (1997).
110. Grodin, supra note 101, at 124-26.
111. International Covenant on Civil and Political Rights, opened for signature Dec. 19,1966, art.
7,999 U.N.T.S. 171,175.
112. Principles for Those in Research and Experimentation, World Medical Assembly, 8th Assembly
(Sept.-Oct 1954), reprinted in Organizational News, 2 WORLD MED. J. 12, 14 (1955).
113. See ThE COUNCIL FOR INTL ORG. OF MED. SCIENCES IN COLLABORATION wIT TIRE WORLD
HEALTH ORG., INTERNATIONAL ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH INVOLVING HUMAN
SUBJECTS, reprinted in HUMAN EUERMENTATION AND MEDICALETHICS, supra note 108, at 387 [hereinafter
WHO/CIOMS GUIDELINES].
114. See Kevin KingA Proposal for the Effective International Regulation of Biomedical Research
Involving Human Subjects, 34 STAN. J. INT'L L 163, 170-90.
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c. The Research Protocol does not Ensure Voluntary, Informed Consent,
and it does not Provide an Ethics Review Board
The WHO/CIOMS Guidelines define vulnerable populations as those
having "a substantial incapacity to protect [their] own interests owing to such
impediments as lack of capability to give informed consent, lack of alternative
means of obtaining medical care or other expensive necessities, or being a
junior or subordinate member of a hierarchical group.""' The Research
Protocol targets the most vulnerable peoples of Senhava- prisoners, people in
outer island villages, orphans, and women and children in health clinics." 6
These are the people who have the least freedom of choice and who are most
vulnerable to manipulation, particularly when M-S uses the Senhavan police to
"provide transportation" to M-S personnel- truly undermining the possibility of
free consent and constituting coercion and duress.1
7
It is unlikely that prisoners would ever be able to give informed consent
because often they have been confined in isolation for so long or to such an
extent that they are not able to weigh options in a meaningful way, as free
citizens are able to do."' Further, because they are forcibly deprived of their
freedom, they often experience a significant lack of self-esteem and diminished
capacities for decision-making." 9 Prisoners may "consent" to medical research
to escape from the violent atmosphere of most prisons to a more regulated and
protected environment provided through medical experimentation. " They may
simply stop caring about their own well-being- defeated and discouraged by
prison life- and helplessly "consent" to medical experimentation.' 2 ' Further, if
a cure is found for MHVD, with or without the use of prisoners, it is unlikely
that they will be one of the groups to benefit from the use of any such vaccine,
thereby increasing their exploitation. 22
People in outer island villages do not share the same basis of knowledge
and education with populations residing in more developed areas; they are
therefore unable to give informed consent. Traditionally, isolated populations-
especially isolated populations in developing countries like Senhava- lack a
scientific conception of disease and a comprehension of the technical details of
115. WHO/CIOMS GDEUNES, supra note 113, at 11.
116. See Comp. 115.
117. See id.
118. See Simon N. Verdun-Jones et al., Prisoners as Subjects of Biomedical Experimentation:
Examining the Arguments For andAgainsta Total Ban, in REsEARcHONHUMAN SuBiECTS 503,506 (David
N. Weisswb ed., 1998).
119. See id.
120. See id. at 521-22.
121. Id. at 522.
122. Id. at 523.
2000]
198 ILSA Journal of International & Comparative Law [Vol. 7:175
proposed research.' The peculiar qualities of remote, isolated villages make
the Protocol's "informed" Consent Form completely inadequate; indeed, it is
a tool for exploitation.
Conducting the Research Protocol on orphans and women and children in
health clinics exploits Senhavans who are in desperate situations and who are
least able to freely decline taking part in trials that are sponsored, promoted and
apparently required by the Senhavan government."2 The Consent Form's
provision allowing a legally responsible person to give consent for a minor is
especially problematic with respect to orphans because Senhava may be the
legally responsible authority that provides consent for such testing.
With respect to all of the vulnerable populations discussed above, there is
a further problem involving the use of placebos. Assuming, arguendo, that the
targeted groups could give informed consent, such consent would cease to be
informed when they are given placebos because the Consent Form does not
mention that placebos may be used." The groups have never consented to the
possibility of ingesting placebos. Naturally, another immediate problem
follows: If the targeted populations believe that they are being treated by a
vaccine, then they may continue to engage in conduct which actually spreads
the disease.
Finally, the Research Protocol does not provide for a biomedical ethics
review board to evaluate the Protocol, thereby violating customary international
law and customary international human rights law.
IV. SENHAVA MUST IMMEDIATELY RELEASE GEORGE SMITH BECAUSE HIS
DETENTION VIOLATES INTERNATIONAL LAW
Because the Republic of Nemin, of which George Smith is a citizen, has
declined to intervene in the case at bar or to otherwise participate in the
proceedings," Kuraca has jurisdiction to demand the immediate release of
Smith from detention- in Senhava. If Kuraca did not assert his claims, Smith
would be left without a remedy. Further, Smith's status as an agent of the
Kuracan Medical Product Regulation Agency creates a bond between Kuraca
and Smith, thereby giving Kuraca an interest in asserting Smith's rights. 27
123. Carel B. ljsselmuiden & Ruth R. Paden, Medical Research and the Principle of Respect for
Persons in Non-Western Cultures, in NAZI DOCTORS, supra note 101, at 286-87.
124. See Comp. 115.
125. See Christian Mormont, Ethical Questions Pertaining to the Use of Placebos, in RESEARCH
ON HUMAN SUBJEC, supra note 118, at 541-42.
126. See Comp. I 11.
127. See J. BiuERLY, TE LAW OF NATIONS 276-87 (6th ed., 1963); see also Comp. I 11.
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Further, Senhava has violated Smith's rights under international law.
Article 10 of the Universal Declaration of Human Rights, which constitutes
customary international law," states that "[e]veryone is entitled in full equality
to a fair and public hearing by an independent and impartial tribunal, in the
determination of his rights and obligations and of any criminal charge against
him." Senhavan authorities are holding Smith without bail; they have presented
no formal charges against him; they have not scheduled a trial date.'29
Senhavan authorities arrested Smith for performing duties that Senhava
previously agreed he should perform.' ° Therefore, his subsequent arrest for
performing precisely these duties is also arbitrary, thereby violating Article 9
of the Universal Declaration of Human Rights.
V. SENHAVA SHOULD PAY COMPENSATION FOR INJURIES CAUSED BY ITS
BREACHES OF INTERNATIONAL LAW
Customary international law dictates that Senhava should remedy its
breaches 3' of the TAC the CEDAW, the CAT, the CRC, and customary
international law.'32 Thus, Senhava should pay compensation for injuries
caused and cease all conduct that resulted in the breaches. Furthermore, a state
may recover for injuries to its nationals, such as Megaceutical, M-S, 33 and the
Kuracan shareholders of M-S." Therefore, Senhava should compensate
Kuraca for Megaceutical's advance payment of Euros 2,000,000 and for all
damages arising from M-S's closing.
CONCLUSION AND PRAYER FOR RELIEF
For the foregoing reasons, Kuraca respectfully requests this Honorable
Court to assert jurisdiction over the subject matter of this case; find that Kuraca
properly applied its National Health Law 1006 to M-S in compliance with
international law; order the immediate release of George Smith; declare that
Kuraca incurred no liability to Senhava in this matter; and order Senhava to
rescind the order closing the offices of M-S and to return the advance payment
of 2,000,000 Euros to the Senhavan Ministry of Health.
128. See discussion supra Part IlA.
129. See Comp. 25.
130. See id. 11.
131. U.S. Diplomatic and Consular Staff in Tehran (U.S. v. Iran), 1980 I.C.J. 3,41-42 (May 24);
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